Medicine Overview

Indication

Know Medicine, Follow Guideline

Adult Dose

Clinical InformationAdministration Information
Indication: Palliation of malignant neoplasms
Age: Adult
Dose: Intravenous – 12 mg/kg/day
Duration: 3-4 days
Note: Maximum 0.8-1 g/day; if no toxicity occurs, may be followed after 1 day with 6 mg/kg on alternate days for another 3-4 doses. May repeat course 4-6 weeks later or maintenance doses of 5-15 mg/kg (maximum 1 g) may be given weekly.
Indication: Cancers of Colon, Breast, Ovary, Liver, Pancreas, Rectum, Stomach
Age: Adult
Dose: Intravenous – 500 mg/square meter
Duration: Days 1-5
Note: Various protocols exist. Not to exceed 800 mg/day.

Child Dose

Clinical InformationAdministration Information
Age: Child
Dose: Not established
Note: Safety and efficacy not established

Renal Dose

Clinical InformationAdministration Information
Condition: Renal impairment
Dose: Not specified C
olumn E: Note: Dose reduction may be required.
Administration
  • For hospital use only
  • Must be administered by healthcare professionals
Side Effect

Drug Interaction

Drug NameRisk Factors
Warfarin
May increase effects
Vaccines
May reduce response; possibility of generalized infection with live vaccines

Disease Interaction

Disease NameRisk Factors
Mucous Membrane Application
Risk of severe irritation
Depressed Bone Marrow Function
Risk of severe infection

Pregnancy

Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage
Store the vial in original carton not exceeding 25℃. Do not refrigerate. Protect from light.

Data Sources

Clinical & regulatory information on this page is compiled from the following government sources:

DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.